Is fat restriction needed with HMGCoA reductase inhibitor treatment?
Authors:
- Peter M. CliftonPCPeter M. Clifton
- Marion B. WightMWMarion B. Wight
- Paul J. NestelPNPaul J. Nestel
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 93 (1-2) , 59-70
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets1991
- A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.Journal of Clinical Investigation, 1990
- Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.Journal of Clinical Investigation, 1989
- Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.Journal of Clinical Investigation, 1988
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- A COMPUTERISED DIETARY ANALYSIS SYSTEM FOR USE WITH DIET DIARIES OR FOOD FREQUENCY QUESTIONNAIRESCommunity Health Studies, 1984
- Cholesterol feeding increases low density lipoprotein synthesis.Journal of Clinical Investigation, 1983
- Individual Variation in the Effects of Dietary Cholesterol on Plasma Lipoproteins and Cellular Cholesterol Homeostasis in ManJournal of Clinical Investigation, 1981
- Serum cholesterol response to changes in the dietMetabolism, 1965
- PREDICTION OF SERUM-CHOLESTEROL RESPONSES OF MAN TO CHANGES IN FATS IN THE DIETThe Lancet, 1957